Advocates Unite to Oppose Delaney Nomination, Citing History of Pro-Corporate Activism
May 18, 2023 — A group of eight advocacy organizations today wrote to the Senate Judiciary Committee voicing their collective opposition to the nomination of Michael A. Delaney as a United States Circuit Judge for the U.S. Court of Appeals for the First Circuit.
Economic Liberties Applauds Minnesota Legislature for Banning Noncompete Agreements
May 17, 2023 — The American Economic Liberties Project released the following statement following the Minnesota House and Senate passing SF3035 yesterday, which included a provision rendering noncompete agreements void and unenforceable.
In Blocking Amgen-Horizon, FTC Stands Up to Big Pharma Abuse and Defends Patients
May 16, 2023 — In response to news that the Federal Trade Commission is blocking Amgen’s $28 billion acquisition of Horizon Therapeutics, the American Economic Liberties Project released the following statement.
Big Pharma Cheated Americans Out of More $40 Billion, New Economic Liberties and I-MAK Report Finds
May 16, 2023 — The American Economic Liberties Project and I-MAK today released “The Costs of Pharma Cheating,” a blockbuster report that reveals rampant antitrust violations by Big Pharma corporations are costing American patients and government health programs an additional $40 billion on branded pharmaceuticals in 2019.
Solicitor General Defends CFPB Against Rogue Courts and Payday Lenders
May 9, 2023 — In response to a brief filed by the United States Solicitor General in support of the Consumer Financial Protection Bureau in CFPB v CFSA, a case challenging the constitutionality of the CFPB’s funding structure, the American Economic Liberties Project released the following statement.